[Form 4] Avient Corporation Insider Trading Activity

Rhea-AI Filing Summary

Avient Corporation (AVNT) Form 4 filing: Director Patricia Verduin disclosed the acquisition of 1,187 shares of Avient common stock on 06/30/2025. The transaction is coded “A” (acquired) with a stated price of $0, suggesting a grant or similar non-cash transaction. Following this filing, Verduin now directly owns 23,866 shares of AVNT. No sales or derivative security transactions were reported, and there were no indications of 10b5-1 plan usage. The Form was signed on 07/02/2025 by attorney-in-fact Robert K. James.

Positive

• Director increased direct ownership by 1,187 shares, signaling ongoing equity alignment with shareholders.

Negative

• None.

Insights

Securities Analyst

TL;DR: Small share grant to AVNT director; immaterial to float, mildly positive insider-alignment signal.

The filing reflects an additional 1,187 shares (roughly $50k assuming a mid-$40s share price, but the form lists $0, indicating a grant). Post-transaction ownership of 23,866 shares keeps the director’s economic stake modest relative to Avient’s 90 million-plus share base. Insider acquisitions, even as grants, are generally perceived as alignment-positive, yet the size is immaterial to valuation or control. With no derivative activity, dispositions, or 10b5-1 disclaimers, the impact on float, liquidity, and governance is negligible. I view the disclosure as neutral-to-slightly positive—an expected periodic equity award rather than an active open-market purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verduin Patricia

(Last) (First) (Middle)

AVIENT CORPORATION

33587 WALKER ROAD

(Street)

AVON LAKE OH 44012

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		1,187	A	$0	23,866	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Robert K. James, Power of Attorney for Patricia Verduin	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Avient (AVNT) shares did Director Patricia Verduin acquire?

The Form 4 reports an acquisition of 1,187 AVNT common shares on 06/30/2025.

What is Patricia Verduin’s total AVNT shareholding after the transaction?

Her direct beneficial ownership increased to 23,866 shares following the reported acquisition.

Was the acquisition an open-market purchase?

The transaction code is “A” with a price of $0, implying a non-cash grant or award, not an open-market buy.

Did the filing include any derivative security transactions?

No. Table II shows no derivative securities acquired or disposed of.

When was the Form 4 for Avient (AVNT) filed?

The document was signed and filed on 07/02/2025.